Anti-Xa monitoring of low-molecular-weight heparin in adult patients with cancer

Lisa Baumann Kreuziger, Michael Streiff

Research output: Contribution to journalArticle

Abstract

A 68-year-old man developed a right femoral vein deep vein thrombosis and bilateral pulmonary embolism while receiving chemotherapy for stage IV prostate cancer. His creatinine at diagnosis is 1.4 mg/dL with an estimated clearance of 63 mL/min. In patients with cancer, should low-molecular-weight heparin treatment be dosed according to weight, or adjusted using anti-Xa levels?

Original languageEnglish (US)
Pages (from-to)206-207
Number of pages2
JournalHematology
Volume2016
Issue number1
DOIs
StatePublished - Jan 1 2016

ASJC Scopus subject areas

  • Hematology

Fingerprint Dive into the research topics of 'Anti-Xa monitoring of low-molecular-weight heparin in adult patients with cancer'. Together they form a unique fingerprint.

  • Cite this